Pillstats
Rx only · Tablet, Film Coated · Oral

Ambrisentan

Brands: Letairis · Ambrisentan

12 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US24 NDCs
12 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)358274
US makers12 labelers
Packages58
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.61$5.22$7.83$10.44Dec 2025Apr 2026Jul 2026
$8.586
Latest avg · Jul 22, 2026
-5%
Since Dec 17, 2025
12
Active US suppliers
34%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.6K7.2K11K14K2025 Q12025 Q22025 Q32025 Q42026 Q1
11K
Rx · 2026 Q1
345K
Units dispensed
-9%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it12 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Zydus Pharmaceuticals USA Inc.unknown10SUPPLYING
Gilead Sciences, Inc.unknown10SUPPLYING
Zydus Lifesciences Limitedunknown10SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown8SUPPLYING
Cipla USA Inc.unknown4SUPPLYING
SIGMAPHARM LABORATORIES, LLCunknown4SUPPLYING
Quallent Pharmaceuticals Health LLCunknown2SUPPLYING
A-S Medication Solutionsunknown2SUPPLYING
Apotex Corp.unknown2SUPPLYING
Golden State Medical Supply, Inc.unknown2SUPPLYING
Aurobindo Pharma Limitedunknown2SUPPLYING
Mylan Pharmaceuticals Inc.unknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.